HRP20130278T1 - Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase - Google Patents

Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase

Info

Publication number: HRP20130278T1
Authority: HR; Croatia
Prior art keywords: yloxy; phenyl; thiazolopyrazin; thiazolopyridin; leukotriene
Prior art date: 2008-04-11

Application number

HRP20130278AT

Other languages

English (en)

Inventor

Genesis M. Bacani

Diego Broggini

Eugene Y. Cheung

Christa C. Chrovian

Xiaohu Deng

Anne M. Fourine

Laurent Gomez

Cheryl A. Grice

Aaron M. Kearney

Adrienne M. Landry-Bayle

Alice Lee-Dutra

Jimmy T. Liang

Susanne Lochner

Neelakandha S. Mani

Alejandro Santillan

Kathleen C. Sappy

Kia Sepassi

Virginia M. Tanis

Alvah T. Wickboldt

John J.M. Wiener

Hartmut Zinser

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-11

Filing date

2013-03-27

Publication date

2013-06-30

2013-03-27 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2013-06-30 Publication of HRP20130278T1 publication Critical patent/HRP20130278T1/hr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

HRP20130278AT 2008-04-11 2013-03-27 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase HRP20130278T1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4434908P	2008-04-11	2008-04-11
US14912909P	2009-02-02	2009-02-02

Publications (1)

Publication Number	Publication Date
HRP20130278T1 true HRP20130278T1 (en)	2013-06-30

Family

ID=41130551

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HRP20131192AT HRP20131192T1 (hr)	2008-04-11	2009-04-09	Tiazolpiridin-2-iloksi-fenil i amini tiazolpirazin-2-iloksi fenila kao modulatori leukotrien a4 hidrolaze
HRP20130278AT HRP20130278T1 (en)	2008-04-11	2013-03-27	Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HRP20131192AT HRP20131192T1 (hr)	2008-04-11	2009-04-09	Tiazolpiridin-2-iloksi-fenil i amini tiazolpirazin-2-iloksi fenila kao modulatori leukotrien a4 hidrolaze

Country Status (35)

Country	Link
US (3)	US7939527B2 (hr)
EP (2)	EP2336125B1 (hr)
JP (2)	JP5530423B2 (hr)
KR (1)	KR101228378B1 (hr)
CN (1)	CN102056933B (hr)
AR (1)	AR072353A1 (hr)
AU (1)	AU2009234140B2 (hr)
BR (1)	BRPI0911336A2 (hr)
CA (1)	CA2721099C (hr)
CL (1)	CL2009000877A1 (hr)
CO (1)	CO6260069A2 (hr)
CY (1)	CY1114628T1 (hr)
DK (2)	DK2268646T3 (hr)
EA (1)	EA018802B1 (hr)
EC (1)	ECSP10010558A (hr)
ES (2)	ES2440746T3 (hr)
HN (1)	HN2010002074A (hr)
HR (2)	HRP20131192T1 (hr)
IL (2)	IL208480A (hr)
JO (1)	JO2911B1 (hr)
MX (1)	MX2010011154A (hr)
MY (1)	MY157597A (hr)
NI (1)	NI201000168A (hr)
NZ (2)	NZ588341A (hr)
PE (1)	PE20091779A1 (hr)
PH (1)	PH12013500094B1 (hr)
PL (2)	PL2336125T3 (hr)
PT (2)	PT2268646E (hr)
RS (2)	RS53081B (hr)
SI (2)	SI2268646T1 (hr)
SV (1)	SV2010003694A (hr)
TW (2)	TW201420100A (hr)
UY (1)	UY31760A (hr)
WO (1)	WO2009126806A2 (hr)
ZA (1)	ZA201008054B (hr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1976828T (pt)	2005-12-29	2017-03-10	Celtaxsys Inc	Derivados de diamina como inibidores de leucotrieno a4 hidrolase
CN102056933B (zh) *	2008-04-11	2014-09-17	詹森药业有限公司	作为白三烯a4水解酶调节剂的噻唑并吡啶-2-基氧基-苯基和噻唑并吡嗪-2-基氧基-苯基胺类
WO2013134226A1 (en) *	2012-03-06	2013-09-12	Boehringer Ingelheim International Gmbh	Benzodioxanes for inhibiting leukotriene production
WO2013131901A1 (en)	2012-03-06	2013-09-12	Boehringer Ingelheim International Gmbh	Benzodioxanes in combination with other actives for inhibiting leukotriene production
JP6256467B2 (ja)	2012-07-17	2018-01-10	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ロイコトリエン生成を阻害するピラゾール誘導体
EP2746259A1 (en)	2012-12-21	2014-06-25	Basf Se	Substituted [1,2,4]triazole and imidazole compounds
EP2746260A1 (en)	2012-12-21	2014-06-25	Basf Se	Substituted [1,2,4]triazole and imidazole compounds
ES2864862T3 (es)	2013-03-12	2021-10-14	Celltaxis Llc	Métodos de inhibición de la leucotrieno A4 hidrolasa
RU2690489C2 (ru) *	2013-03-14	2019-06-04	Селтакссис, Инк.	Ингибиторы лейкотриен а4-гидролазы
JP2016513681A (ja)	2013-03-14	2016-05-16	セルタクシス，インコーポレイテッド	ロイコトリエンａ４加水分解酵素の阻害剤
AU2019278935B2 (en)	2018-05-31	2025-02-13	Celltaxis, Llc	Method of reducing pulmonary exacerbations in respiratory disease patients
JP7680955B2 (ja) *	2019-01-11	2025-05-21	ネイジスファーマシューティカルズインコーポレイテッド	ロイコトリエン合成阻害剤

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5008A (en) *		1847-03-13		Machinery for cleaning
IL59004A0 (en) *	1978-12-30	1980-03-31	Beecham Group Ltd	Substituted benzamides their preparation and pharmaceutical compositions containing them
FR2446823A1 (fr)	1979-01-16	1980-08-14	Delalande Sa	Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
FR2476088A2 (fr) *	1979-01-16	1981-08-21	Delalande Sa	Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
US4329466A (en) *	1979-01-16	1982-05-11	Delalande S.A.	Certain nor-tropan-8-amine-3-aryl or heteroaryl derivatives
US4321378A (en) *	1979-01-16	1982-03-23	Delalande S.A.	8-(5-Pyrimidinecarboxamide)nor-tropane derivatives
US4424358A (en) *	1979-01-16	1984-01-03	Delalande S.A.	β-3-Amino nor-tropane compounds
US4352802A (en) *	1980-06-10	1982-10-05	Beecham Group Limited	Bicyclo[3.3.1]nonyl-benzamide
NZ199080A (en) *	1980-12-12	1984-07-31	Beecham Group Ltd	2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
US4432983A (en) *	1981-04-30	1984-02-21	Research Corporation	Conformationally restricted histamine H2 -receptor antagonists containing a tropane ring
DE3137996A1 (de) *	1981-09-24	1983-04-28	Hoechst Ag, 6230 Frankfurt	Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel
US4571396A (en) *	1984-04-16	1986-02-18	Warner-Lambert Company	Antibacterial agents
US4873346A (en) *	1985-09-20	1989-10-10	The Upjohn Company	Substituted benzothiazoles, benzimidazoles, and benzoxazoles
NZ222047A (en)	1986-10-08	1991-01-29	Bristol Myers Co	Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
CA1319144C (en) *	1986-11-14	1993-06-15	Quirico Branca	Tetrahydronaphthalene derivatives
JPS63170356A (ja)	1986-12-30	1988-07-14	Yamanouchi Pharmaceut Co Ltd	アニリン誘導体及びその製造法
FI91859C (fi) *	1987-06-17	1994-08-25	Eisai Co Ltd	Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
US5070094A (en)	1989-09-05	1991-12-03	G. D. Searle & Co.	N-benzyltropaneamides
US5220063A (en) *	1991-05-10	1993-06-15	Hoechst Celanese Corporation	Method for the preparation of arylalkanolacylamides
US5296486A (en) *	1991-09-24	1994-03-22	Boehringer Ingelheim Pharmaceuticals, Inc.	Leukotriene biosynthesis inhibitors
US5472964A (en) *	1992-12-22	1995-12-05	Merck Frosst Canada, Inc.	Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
TW251287B (hr)	1993-04-30	1995-07-11	Nissei Co Ltd
US6506876B1 (en)	1994-10-11	2003-01-14	G.D. Searle & Co.	LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5585492A (en) *	1994-10-11	1996-12-17	G. D. Searle & Co.	LTA4 Hydrolase inhibitors
US5700816A (en)	1995-06-12	1997-12-23	Isakson; Peter C.	Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US6632976B1 (en) *	1995-08-29	2003-10-14	Kirin Beer Kabushiki Kaisha	Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
US5794887A (en) *	1995-11-17	1998-08-18	Komerath; Narayanan M.	Stagnation point vortex controller
PT880363E (pt) *	1996-02-13	2002-12-31	Searle & Co	Combinacoes com efeitos imunossupressores cntendo um inibidor da ciclooxigenase-2 e um inibidor da hidrolase do leucotrieno a4
US6110994A (en) *	1996-06-14	2000-08-29	Cabot Corporation	Polymeric products containing modified carbon products and methods of making and using the same
US6110944A (en)	1997-03-12	2000-08-29	G. D. Searle & Co.	LTA4, hydrolase inhibitors
US6632823B1 (en) *	1997-12-22	2003-10-14	Merck & Co., Inc.	Substituted pyridine compounds useful as modulators of acetylcholine receptors
US6432976B1 (en) *	1999-10-29	2002-08-13	Merck & Co., Inc.	8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6559140B2 (en)	2000-03-09	2003-05-06	Abbott Laboratories	Cyclic and bicyclic diamino histamine-3 receptor antagonists
MY137020A (en)	2000-04-27	2008-12-31	Abbott Lab	Diazabicyclic central nervous system active agents
FR2831884B1 (fr) *	2001-11-02	2003-12-26	Pf Medicament	Nouveaux derives amides heteroaromatiques de 3 beta-amino azabicyclooctane, leur procede de preparation et leurs applications en therapeutique
US7152144B2 (en) *	2002-05-29	2006-12-19	Hitachi, Ltd.	Centralized storage management method
US7329682B2 (en) *	2003-04-03	2008-02-12	Ewha University-Industry Collaboration Foundation	Method for inhibiting 5-lipoxygenase using a benzoxazole derivative
SE0301373D0 (sv) *	2003-05-09	2003-05-09	Astrazeneca Ab	Novel compounds
WO2004103959A2 (en)	2003-05-16	2004-12-02	Ambit Biosciences Corporation	Heterocyclic compounds and uses thereof
DE602004015620D1 (de) *	2003-07-28	2008-09-18	Janssen Pharmaceutica Nv	Benzimidazol-, benzothiazol- und benzoxazolderivate und deren verwendung als lta4h-modulatoren
CN101407471A (zh) *	2003-08-29	2009-04-15	小野药品工业株式会社	能够结合s1p受体的化合物及其药物用途
US7435831B2 (en) *	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
TW200610761A (en)	2004-04-23	2006-04-01	Astrazeneca Ab	Chemical compounds
JP2008503585A (ja)	2004-06-22	2008-02-07	シェーリング　コーポレイション	カンナビノイドレセプターリガンド
GB2415818B (en)	2004-06-30	2008-12-31	Autoliv Dev	Arrangement for triggering a vehicle safety device
BRPI0515164A (pt)	2004-09-13	2008-07-08	Ono Pharmaceutical Co	derivado heterocìclico nitrogenado e medicamento contendo o mesmo como um ingrediente ativo
BRPI0607742A2 (pt) *	2005-03-31	2009-09-29	Janssen Pharmaceutica Nv	moduladores de fenil e piridil lta4h
ES2277745B1 (es)	2005-06-14	2008-06-01	Laboratorios Almirall S.A.	Derivados n-amida de 8-azabiciclo /3.2.1/oct-3-ilo como antagonistas de ccr1.
GB0514018D0 (en)	2005-07-07	2005-08-17	Ionix Pharmaceuticals Ltd	Chemical compounds
PT1976828T (pt)	2005-12-29	2017-03-10	Celtaxsys Inc	Derivados de diamina como inibidores de leucotrieno a4 hidrolase
US20090156465A1 (en)	2005-12-30	2009-06-18	Sattigeri Jitendra A	Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
JP5363315B2 (ja)	2006-06-06	2013-12-11	コーナーストーンセラピューティクスインコーポレイテッド	新規ピペラジン、医薬組成物、およびその使用方法
WO2008016811A2 (en)	2006-07-31	2008-02-07	Neurogen Corporation	Aminopiperidines and realted compounds
EP2121676A1 (en) *	2006-12-19	2009-11-25	Auspex Pharmaceuticals, Inc.	Preperation and utility of ccr5 inhibitors
TW200906396A (en) *	2007-02-14	2009-02-16	Janssen Pharmaceutica Nv	LTA4H modulators and uses thereof
TW200932236A (en) *	2007-10-31	2009-08-01	Janssen Pharmaceutica Nv	Aryl-substituted bridged diamines as modulators of leukotriene A4 hydrolase
CN102056933B (zh) *	2008-04-11	2014-09-17	詹森药业有限公司	作为白三烯a4水解酶调节剂的噻唑并吡啶-2-基氧基-苯基和噻唑并吡嗪-2-基氧基-苯基胺类

2009
- 2009-04-09 CN CN200980122416.8A patent/CN102056933B/zh not_active Expired - Fee Related
- 2009-04-09 EP EP11159236A patent/EP2336125B1/en active Active
- 2009-04-09 CA CA2721099A patent/CA2721099C/en not_active Expired - Fee Related
- 2009-04-09 PT PT97295968T patent/PT2268646E/pt unknown
- 2009-04-09 PL PL11159236T patent/PL2336125T3/pl unknown
- 2009-04-09 MY MYPI2010004692A patent/MY157597A/en unknown
- 2009-04-09 SI SI200930743T patent/SI2268646T1/sl unknown
- 2009-04-09 BR BRPI0911336-3A patent/BRPI0911336A2/pt not_active Application Discontinuation
- 2009-04-09 SI SI200930535T patent/SI2336125T1/sl unknown
- 2009-04-09 PL PL09729596T patent/PL2268646T3/pl unknown
- 2009-04-09 HR HRP20131192AT patent/HRP20131192T1/hr unknown
- 2009-04-09 DK DK09729596.8T patent/DK2268646T3/da active
- 2009-04-09 ES ES09729596.8T patent/ES2440746T3/es active Active
- 2009-04-09 PT PT111592366T patent/PT2336125E/pt unknown
- 2009-04-09 DK DK11159236.6T patent/DK2336125T3/da active
- 2009-04-09 NZ NZ588341A patent/NZ588341A/en not_active IP Right Cessation
- 2009-04-09 RS RS20130527A patent/RS53081B/en unknown
- 2009-04-09 JP JP2011504176A patent/JP5530423B2/ja not_active Expired - Fee Related
- 2009-04-09 ES ES11159236T patent/ES2400875T3/es active Active
- 2009-04-09 RS RS20130120A patent/RS52712B/en unknown
- 2009-04-09 WO PCT/US2009/040070 patent/WO2009126806A2/en active Application Filing
- 2009-04-09 EA EA201071186A patent/EA018802B1/ru unknown
- 2009-04-09 MX MX2010011154A patent/MX2010011154A/es active IP Right Grant
- 2009-04-09 KR KR1020107025118A patent/KR101228378B1/ko active Active
- 2009-04-09 AU AU2009234140A patent/AU2009234140B2/en not_active Ceased
- 2009-04-09 EP EP09729596.8A patent/EP2268646B9/en active Active
- 2009-04-09 CL CL2009000877A patent/CL2009000877A1/es unknown
- 2009-04-09 US US12/421,406 patent/US7939527B2/en active Active
- 2009-04-09 NZ NZ599853A patent/NZ599853A/xx not_active IP Right Cessation
- 2009-04-09 JO JO2009128A patent/JO2911B1/en active
- 2009-04-10 TW TW103104197A patent/TW201420100A/zh unknown
- 2009-04-10 TW TW098111909A patent/TWI461196B/zh not_active IP Right Cessation
- 2009-04-13 PE PE2009000508A patent/PE20091779A1/es active IP Right Grant
- 2009-04-13 AR ARP090101295A patent/AR072353A1/es unknown
- 2009-04-13 UY UY0001031760A patent/UY31760A/es unknown
2010
- 2010-10-05 IL IL208480A patent/IL208480A/en active IP Right Grant
- 2010-10-11 HN HN2010002074A patent/HN2010002074A/es unknown
- 2010-10-11 NI NI201000168A patent/NI201000168A/es unknown
- 2010-10-11 SV SV2010003694A patent/SV2010003694A/es unknown
- 2010-10-20 EC EC2010010558A patent/ECSP10010558A/es unknown
- 2010-10-22 CO CO10131314A patent/CO6260069A2/es active IP Right Grant
- 2010-11-10 ZA ZA2010/08054A patent/ZA201008054B/en unknown
2011
- 2011-03-02 US US13/039,105 patent/US20110190503A1/en not_active Abandoned
- 2011-03-02 US US13/039,017 patent/US8357684B2/en not_active Expired - Fee Related
2013
- 2013-01-14 PH PH12013500094A patent/PH12013500094B1/en unknown
- 2013-03-27 HR HRP20130278AT patent/HRP20130278T1/hr unknown
- 2013-05-09 IL IL226244A patent/IL226244A/en active IP Right Grant
- 2013-11-20 CY CY20131101029T patent/CY1114628T1/el unknown
- 2013-12-25 JP JP2013266767A patent/JP5675943B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2009126806A3 (en)	2010-03-18
CA2721099C (en)	2017-04-25
RS53081B (en)	2014-06-30
NI201000168A (es)	2015-05-27
TW201002320A (en)	2010-01-16
CA2721099A1 (en)	2009-10-15
RS52712B (en)	2013-08-30
JP2011516571A (ja)	2011-05-26
PL2336125T3 (pl)	2013-06-28
UY31760A (es)	2009-11-10
JP5675943B2 (ja)	2015-02-25
IL208480A0 (en)	2010-12-30
US20090258854A1 (en)	2009-10-15
NZ599853A (en)	2012-08-31
EA018802B1 (ru)	2013-10-30
US20110159563A1 (en)	2011-06-30
CN102056933A (zh)	2011-05-11
CL2009000877A1 (es)	2009-11-27
IL208480A (en)	2014-11-30
AU2009234140B2 (en)	2013-04-11
DK2268646T3 (da)	2013-11-18
PT2268646E (pt)	2013-12-10
JP5530423B2 (ja)	2014-06-25
HRP20131192T1 (hr)	2014-01-17
ES2400875T3 (es)	2013-04-15
EP2336125B1 (en)	2013-01-09
PE20091779A1 (es)	2009-11-14
CY1114628T1 (el)	2016-10-05
PH12013500094A1 (en)	2015-02-23
WO2009126806A2 (en)	2009-10-15
SV2010003694A (es)	2011-03-17
PL2268646T3 (pl)	2014-02-28
SI2336125T1 (sl)	2013-04-30
EP2336125A1 (en)	2011-06-22
MY157597A (en)	2016-06-30
HN2010002074A (es)	2012-12-03
KR101228378B1 (ko)	2013-01-31
AR072353A1 (es)	2010-08-25
JO2911B1 (en)	2015-09-15
TW201420100A (zh)	2014-06-01
US20110190503A1 (en)	2011-08-04
IL226244A0 (en)	2013-06-27
PT2336125E (pt)	2013-03-18
ZA201008054B (en)	2012-04-25
US8357684B2 (en)	2013-01-22
SI2268646T1 (sl)	2013-12-31
EP2268646B9 (en)	2014-11-19
EA201071186A1 (ru)	2011-06-30
TWI461196B (zh)	2014-11-21
EP2268646B1 (en)	2013-10-02
JP2014144949A (ja)	2014-08-14
ECSP10010558A (es)	2010-11-30
DK2336125T3 (da)	2013-04-08
WO2009126806A8 (en)	2010-11-18
KR20110013386A (ko)	2011-02-09
IL226244A (en)	2014-12-31
CO6260069A2 (es)	2011-03-22
BRPI0911336A2 (pt)	2021-06-29
HK1152041A1 (en)	2012-02-17
CN102056933B (zh)	2014-09-17
MX2010011154A (es)	2010-12-21
US7939527B2 (en)	2011-05-10
AU2009234140A1 (en)	2009-10-15
PH12013500094B1 (en)	2015-02-23
HK1158208A1 (en)	2012-07-13
EP2268646A2 (en)	2011-01-05
NZ588341A (en)	2012-06-29
ES2440746T3 (es)	2014-01-30

Publication	Publication Date	Title
IL226244A0 (en)	2013-06-27	Thiazolopyridine-2-yloxy-phenyl and thiazolopyrazine-2-yloxy-phenyl amines as leukotriene a4 hydrolase modulators
EP2217237A4 (en)	2011-08-17	ARYL-SUBSTITUTED, FUSED OR FUSED DIAMINES AS MODULATORS OF LEUKOTRIENE A <SB> 4 </ SB> HYDROLASE
GB2472856B (en)	2012-07-11	IL1-RAP modulators and uses thereof
IL247595A0 (en)	2016-11-30	New modulators and methods of use
EP2441257A4 (en)	2012-05-02	MEDIA BRIDGE DEVICE AND METHOD
IL213072A0 (en)	2011-07-31	Microorganism comprising particles and uses of same
ZA201102674B (en)	2011-12-28	Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
EP2299931A4 (en)	2015-07-01	CLOSURE DEVICE AND METHODS OF USE THEREOF
EP2273992A4 (en)	2011-10-05	CHENOLINE AND RELATED ANALOGUE AS SIRTUIN MODULATORS
PL2081586T5 (pl)	2019-04-30	Rspondyny jako modulatory angiogenezy i waskulogenezy
SG10201601792UA (en)	2016-04-28	Novel modulators and methods of use
IL209754A0 (en)	2011-02-28	Diazacarbazoles and methods of use
EP2411050A4 (en)	2013-07-17	ANTIBODY REGIONS WITH A CONSTANT DOMAIN AND THEIR USE
EP2318985A4 (en)	2011-08-24	ECONOMIC MEDIA AND MARKETING SYSTEM
IL209548A0 (en)	2011-01-31	Diazacarbazoles and methods of use
ZA201601457B (en)	2019-04-24	Modulators of 5-ht receptors and methods of use thereof
EP2398978A4 (en)	2014-10-08	SURFACE COMPOSITION AND METHOD OF PROCESSING
EP2346425A4 (en)	2012-04-18	MODULATED STRAIN APPARATUS AND METHODS OF USE
EP2399749A4 (en)	2016-12-28	PRINTER DEVICE AND MAINTENANCE METHOD THEREFOR
EP2421923A4 (en)	2013-05-29	INK COMPOSITIONS AND USE
PL2519939T3 (pl)	2017-04-28	Sposób, obiekt i ich zastosowanie do mocowania plakatów
EP2346894A4 (en)	2012-04-18	TERMOSTABLE CELLULASE AND USE METHOD
TH0901001693A (th)	2016-05-19	ไธแอโซโลพิริดิน-2-อิลออกซิ-เฟนิล และไธแอโซโลพิแรซิน-2-อิลออกซิ-เฟนิล แอมีนเป็นมอดูเลเตอร์ของลิวโคไทรอีน a4 ไฮโดรเลส
HK1157780A (en)	2012-07-06	Amides of diazabicyclooctanes and uses thereof
HK1146389A (en)	2011-06-03	Aryl-substituted bridged or fused diamines as modulators of leukotriene a4 hydrolase